There was an article in Diabetologia 2014 stating that, "Whey protein may represent a novel approach for enhancing glucose-lowering strategies in type 2 diabetes." I wonder why we need these studies as common sense says any time you add protein to a meal digestion will slow and glucose levels won’t …

First it was the Quintessential Quintet, then the Setaceous Sextet, and Septicidal Septet was next in our discussion of causes of hyperglycemia — now, this week in our Homerun Slides, we look at the Ominous Octet and how that affects hyperglycemia and glucose control. Dr. Rudy Bilous, Professor of Clinical …

  In this week’s Homerun Slides, we delve further into the pathophysiology and treatment of type 2 diabetes covering topics including: altered Hypothalamic Function in Response to Glucose Ingestion in Obese Humans; the UKPDS trial – Effect of Glibenclamide and Metformin Therapy on HbA1c; and the ADOPT trial – Effect …

Rudy Bilous MD, FRCP Richard Donnelly MD, PHD, FRCP, FRACP   Diseases with the clinical features of diabetes have been recognised since antiquity. The Ebers papyrus, dating from 1550 BC, describes a polyuric state that resem­bles diabetes. The word ‘diabetes’ was first used by Aretaeus of Cappadocia in the second century AD. …

Coheso, Inc. iOS $2.99/Android $2.99   For your patients on low-carb diets, the CarbsControl App gives the carbohydrate details on over 80,000 foods, the menu items from 300 restaurants, and 500 specific brands. This simple app features daily logs and goal setting to allow patients to monitor and control their …

Can you all help me with a couple of things? I know from experience that many of our readers are very physically active and health conscious. In talking with some of my colleagues, many select lower carb regimens to follow. This often leads us to take on long bouts of …

Afrezza Approved in U.S. For more details, see item#1.

 SCIO – A Pocket-Sized Scanner Reads Molecular Fingerprint of Food, Pharmaceuticals, and More  Consumer Physics unveiled SCiO, a handheld sensor that scans the molecular fingerprint of physical matter and instantly provides information about its chemical makeup. SCiO delivers real-time results to its mobile application on the user’s smartphone via Bluetooth …

New data from the ongoing US Diabetes Prevention Program (DPP) show that randomizing overweight or obese people at high risk for type 2 diabetes to intensive lifestyle change or giving them the oral agent metformin can reduce or delay the development of the disease for as long as 15 years. …

Among patients with type 2 diabetes who start taking insulin, those who attain good glycemic control are less likely to have a major adverse cardiac event (MACE) in the medium term than those who fail to achieve this, a new study suggests. The findings come from the Cardiovascular Risk Evaluation …